HIV Protease Substrate IV

Suppliers

Names

[ CAS No. ]:
128340-47-6

[ Name ]:
HIV Protease Substrate IV

[Synonym ]:
HIV Substrate,KARVNleF(4-NO2)EANle-NH2

Chemical & Physical Properties

[ Molecular Formula ]:
C49H83N15O13

[ Molecular Weight ]:
1090.28000

[ Exact Mass ]:
1089.63000

[ PSA ]:
472.95000

[ LogP ]:
5.10380

MSDS

Click to get detail MSDS

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ RIDADR ]:
NONH for all modes of transport

Articles

Characterization of the murine leukemia virus protease and its comparison with the human immunodeficiency virus type 1 protease.

J. Gen. Virol. 87(Pt 5) , 1321-30, (2006)

The protease (PR) of Murine leukemia virus (MLV) was expressed in Escherichia coli, purified to homogeneity and characterized by using various assay methods, including HPLC-based, photometric and fluo...

Molecular basis for substrate recognition and drug resistance from 1.1 to 1.6 angstroms resolution crystal structures of HIV-1 protease mutants with substrate analogs.

FEBS J. 272(20) , 5265-77, (2005)

HIV-1 protease (PR) and two drug-resistant variants--PR with the V82A mutation (PR(V82A)) and PR with the I84V mutation (PR(I84V))--were studied using reduced peptide analogs of five natural cleavage ...

Interactions of a novel inhibitor from an extremophilic Bacillus sp. with HIV-1 protease: implications for the mechanism of inactivation.

J. Biol. Chem. 276(4) , 2487-93, (2001)

The active site cleft of the HIV-1 protease (PR) is bound by two identical conformationally mobile loops known as flaps, which are important for substrate binding and catalysis. The present article re...


More Articles

Related Compounds

  • ANTHRANILYL-HIV PROTEASE SUBSTRATE IV
  • HIV Protease Substrate VI
  • HIV Protease Substrate VII
  • HIV Protease Substrate 1 TFA
  • HIV Protease Substrate III-B (Native Sequence)
  • hiv protease substrate iii
  • [1-(4-Bromophenyl)-2,2,2-trifluoro-1-phenylethoxy]-trimethylsilane
  • N,N-Diethyl-4-[1-(4-fluorophenyl)-1H,2H,3H,4H,9H-pyrido[3,4-B]indole-2-carbonyl]aniline
  • N-methyl-2-(4-((3-methylpiperidin-1-yl)sulfonyl)benzamido)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxamide
  • 2-(4-((2-ethylpiperidin-1-yl)sulfonyl)benzamido)-N-methyl-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxamide
  • 4-(N-butyl-N-methylsulfamoyl)-N-(4-(6-methylbenzo[d]thiazol-2-yl)phenyl)benzamide
  • 4-(ethylthio)-N-(4-(6-methylbenzo[d]thiazol-2-yl)phenyl)benzamide
  • N-(4-butylphenyl)-1-(4-chlorobenzyl)-2-oxo-1,2-dihydropyridine-3-carboxamide
  • 1-(4-chlorobenzyl)-N-(6-ethoxybenzo[d]thiazol-2-yl)-2-oxo-1,2-dihydropyridine-3-carboxamide
  • 1-(4-chlorobenzyl)-N-(5-(ethylthio)-1,3,4-thiadiazol-2-yl)-2-oxo-1,2-dihydropyridine-3-carboxamide
  • N-{4-[(acetylamino)sulfonyl]phenyl}-1-(4-chlorobenzyl)-2-oxo-1,2-dihydropyridine-3-carboxamide
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.